JPMorgan Maintains Overweight Rating on GoodRx, PT Lowered to $5

martes, 11 de noviembre de 2025, 11:16 am ET1 min de lectura
GDRX--

JPMorgan Maintains Overweight Rating on GoodRx, PT Lowered to $5

JPMorgan Maintains Overweight Rating on GoodRx, PT Lowered to $5

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios